Olema Oncology Jobs in United States

Join to apply for the Director, Clinical Monitoring Oversight role at Olema Oncology · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently i ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. This Senior Director of Clinical Business Operations will support the Clinical Department's initiatives to contribute to the success of our clinical trials. · ...

Olema Oncology is developing better medicines for breast cancer and beyond. We are a pragmatic team driven to imagine and develop meaningful therapies for improving lives. · ...

A biotechnology company seeks a Director of Analytical Development in Boston to lead analytical method development for drug products. The ideal candidate will have a PhD and at least 10 years in relevant industry experience, including leadership in drug substance and quality cont ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

Olema Oncology is developing medicines for breast cancer. · We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. · This role will provide strategic direction and operational oversight of all global monitoring activities across Olema's c ...

About the Role · Director, Analytical Development reporting to the Senior Director, Analytical Chemistry, you will be responsible for driving progress of both early and late‑stage molecules by delivering phase‑appropriate analytical methods and validation. You will drive method i ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

Senior Manager GCP Quality Assurance · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. · Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer wit ...

Job Overview · We are seeking a Senior Manager, Global Regulatory Affairs Strategy who will provide regulatory strategy support in partnership with cross-functional teams and subject matter experts and manage regulatory aspects through all phases of development. · About You · You ...

Senior Manager, Global Regulatory Affairs Strategy · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breas ...

Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

+Job summary · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. · +Lead the development of the New Drug Application (NDA) · Develop innovative global regulatory strategies for the Olema portfolio of products in clinical development and life ...

· Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monothera ...

Sr. Manager GCP Clinical Quality · Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with bloc ...